Organogenesis Holdings Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9,407.7% | -100.0% | – | – | +34.9% | +29.6% | +38.2% | -3.5% | -3.9% | +11.3% | +16.8% | |
| – | +3,789.8% | -99.6% | +2,100.2% | +1,398.5% | +10.4% | +15.0% | +30.8% | -8.0% | +1.4% | +8.7% | +18.8% | |
| – | – | -100.4% | – | – | +48.5% | +35.6% | +40.7% | -2.1% | -5.6% | +12.1% | +16.2% | |
| – | +146.0% | +61.7% | +44.4% | +18.5% | +37.8% | +35.7% | +53.1% | +29.3% | +11.6% | +13.3% | -11.4% | |
| – | -97.0% | +729.5% | +2,100.2% | +3,427.2% | +22.6% | +1.1% | +21.9% | +14.0% | -5.2% | +9.9% | +12.2% | |
| – | +3,358.2% | -99.8% | +97,648.9% | -15.3% | +24.4% | +4.4% | +25.3% | +15.2% | -2.9% | +17.0% | +0.6% | |
| – | – | – | -2,300.2% | – | – | – | +170.5% | -69.1% | -43.8% | -110.2% | – | |
| – | – | – | -55.6% | +334.5% | -17.1% | +25.4% | -35.8% | -72.2% | +9.0% | -29.5% | +47.7% | |
| – | – | – | – | – | – | – | +255.1% | -67.9% | -48.8% | -127.0% | – | |
| – | – | – | – | – | +78.6% | +253.3% | -5,970.9% | – | +14.7% | -167.3% | – | |
| – | – | – | – | – | – | – | +446.6% | -83.5% | -68.2% | -82.6% | +4,201.0% | |
| – | – | – | -164.6% | – | – | – | +133.7% | -53.7% | -10.6% | -56.3% | +368.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.